Browsing by Subject "Breast Cancer Lymphedema"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    ASO Author Reflections: Immediate Lymphatic Reconstruction: A Proactive Approach to Breast Cancer-Related Lymphedema
    (Springer, 2021-03) Cook, Julia A.; Hassanein, Aladdin H.; Surgery, School of Medicine
  • Thumbnail Image
    Item
    Immediate Lymphatic Reconstruction to Prevent Breast Cancer-Related Lymphedema: A Systematic Review
    (Liebert, 2022-04) Cook, Julia A.; Sinha, Mithun; Lester, Mary; Fisher, Carla S.; Sen, Chandan K.; Hassanein, Aladdin H.; Medicine, School of Medicine
    Significance: Lymphedema is chronic limb swelling from lymphatic dysfunction. The condition affects up to 250 million people worldwide. In breast cancer patients, lymphedema occurs in 30% who undergo axillary lymph node dissection (ALND). Recent Advances: Immediate lymphatic reconstruction (ILR), also termed Lymphatic Microsurgical Preventing Healing Approach (LyMPHA), is a method to decrease the risk of lymphedema by performing prophylactic lymphovenous anastomoses at the time of ALND. The objective of this study is to assess the risk reduction of ILR in preventing lymphedema. Critical Issues: Lymphedema has significant effects on the quality of life and morbidity of patients. Several techniques have been described to manage lymphedema after development, but prophylactic treatment of lymphedema with ILR may decrease risk of development to 6.6%. Future Directions: Long-term studies that demonstrate efficacy of ILR may allow for prophylactic management of lymphedema in the patient undergoing lymph node dissection.